Recent Finacing
Recent Raise
NanoSyrinx develops engineered, non‑viral nanosyringes for cell‑selective intracellular cytosolic delivery of peptides, proteins, gene editors and enzymes for in vivo therapeutics and ex vivo cell engineering.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at NanoSyrinx.
